SODIUM ASCORBATE POTENTIATES THE GROWTH INHIBITORY EFFECT OF CERTAIN AGENTS ON NEURO-BLASTOMA CELLS IN CULTURE

被引:129
作者
PRASAD, KN [1 ]
SINHA, PK [1 ]
RAMANUJAM, M [1 ]
SAKAMOTO, A [1 ]
机构
[1] BHAGALPUR UNIV,BHAGALPUR,INDIA
关键词
D O I
10.1073/pnas.76.2.829
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mouse neuroblastoma (NB) cells in culture were more sensitive to sodium L-ascorbate than were rat glioma cells by the criterion of growth inhibition (due to cell death and reduction in cell division). Sodium L-ascorbate at nonlethal concentrations potentiated the effect of 5-fluorouracil (FUra), x-irradiation, bleomycin, RO20-1724, prostaglandin E1, and sodium butyrate on NB cells but did not produce such an effect on glioma cells. Sodium L-ascorbate did not enhance the effect of vincristine, 6-thioguanine, or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) except at higher drug doses and it reduced the cytotoxic effect of methotrexate and 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) on NB cells. Sodium D-ascorbate produced effects similar to those produced by sodium L-ascorbate on NB cells. L-Ascorbic acid-2-sulfate (barium salt) affected neither the growth rate nor the effect of 5-FUra on NB cells. Glutathione, a reducing agent, was more toxic to NB cells in comparison to D- or L-ascorbate; however, at a similar concentration it failed to potentiate the effect of 5-FUra on NB cells.
引用
收藏
页码:829 / 832
页数:4
相关论文
共 18 条
[1]  
ARMSTRONG D, 1977, CANCER BIOCHEM BIOPH, V2, P1
[2]   SYNERGISTIC KILLING OF EHRLICH ASCITES CARCINOMA CELLS BY ASCORBATE AND 3-AMINO-1,2,4-TRIAZOLE [J].
BENADE, L ;
HOWARD, T ;
BURK, D .
ONCOLOGY, 1969, 23 (01) :33-&
[3]   DIFFERENTIATED RAT GLIAL CELL STRAIN IN TISSUE CULTURE [J].
BENDA, P ;
LIGHTBODY, J ;
SATO, G ;
LEVINE, L ;
SWEET, W .
SCIENCE, 1968, 161 (3839) :370-+
[4]   PARTIAL MYELOPEROXIDASE DEFICIENCY IN A CASE OF PRELEUKEMIA .1. STUDIES OF FINE-STRUCTURE AND PEROXIDASE SYNTHESIS OF PROMYELOCYTES [J].
BRETONGORIUS, J ;
HOUSSAY, D ;
DREYFUS, B .
BRITISH JOURNAL OF HAEMATOLOGY, 1975, 30 (03) :273-&
[5]   ORTHOMOLECULAR TREATMENT OF CANCER .1. ROLE OF ASCORBIC-ACID IN HOST RESISTANCE [J].
CAMERON, E ;
PAULING, L .
CHEMICO-BIOLOGICAL INTERACTIONS, 1974, 9 (04) :273-283
[6]   SUPPLEMENTAL ASCORBATE IN SUPPORTIVE TREATMENT OF CANCER - PROLONGATION OF SURVIVAL TIMES IN TERMINAL HUMAN CANCER .1. [J].
CAMERON, E ;
PAULING, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (10) :3685-3689
[7]   ORTHOMOLECULAR TREATMENT OF CANCER .2. CLINICAL TRIAL OF HIGH-DOSE ASCORBIC-ACID SUPPLEMENTS IN ADVANCED HUMAN CANCER [J].
CAMERON, E ;
CAMPBELL, A .
CHEMICO-BIOLOGICAL INTERACTIONS, 1974, 9 (04) :285-315
[8]  
CATOVSKY D, 1972, SCAND J HAEMATOL, V9, P142
[9]   DEGRADATION OF MEMBRANE PHOSPHOLIPIDS AND THIOLS IN PEROXIDE HEMOLYSIS - STUDIES IN VITAMIN E DEFICIENCY [J].
JACOB, HS ;
LUX, SE .
BLOOD, 1968, 32 (04) :549-&
[10]  
MAPSON LW, 1969, VITAMINS, P386